Avid Bioservices Stock (NASDAQ:CDMO), Quotes and News Summary

Q: What sector and industry does Avid Bioservices (CDMO) operate in?

Avid Bioservices is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Avid Bioservices Stock (NASDAQ: CDMO) stock price, news, charts, stock research, profile.

Open	$6.640
Close	$6.520
Volume / Avg.	707.733K / 1.329M
Day Range	6.510 - 6.825
52 Wk Range	4.071 - 19.970
Market Cap	$412.320M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	19.09%
Days to Cover	9.07

Recent News

S&P 500 Gains 1%; Kroger Earnings Top Views

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 250 points on Thursday. The Dow traded up 0.34% to 38,793.79 while the NASDAQ rose 1.63% to 16,292.61. The S&P 500 also rose, gaining, 1.06% to 5,158.91.

Avi Kapoor

Biotech/Pharma Contract Service Provider Avid Bioservices Sees Lower Than Expected Q3 Sales, Sticks To Annual Guidance

Avid Bioservices' Q3 fiscal 2024 report: $33.8 million revenues, 11% Y/Y decrease, $41 million new orders, $206 million backlog. Operating loss at $4 million. Completed CGT facility. Fiscal year 2024 revenue guidance: $137-$147 million.

Vandana Singh

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Avid Bioservices Inc

Sector

Health Care

Industry

Biotechnology

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Cu...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Avid Bioservices (CDMO) stock?

You can purchase shares of Avid Bioservices (NASDAQ: CDMO) through any online brokerage.

View our list of the best stock brokerages.

Who are Avid Bioservices's (CDMO) competitors?

Other companies in Avid Bioservices’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), Replimune Group (NASDAQ:REPL), CareDx (NASDAQ:CDNA) and Tevogen Bio Holdings (NASDAQ:TVGN).

What is the target price for Avid Bioservices (CDMO) stock?

The latest price target for Avid Bioservices (NASDAQ: CDMO) was reported by Stephens & Co. on Monday, March 11, 2024. The analyst firm set a price target for 12.00 expecting CDMO to rise to within 12 months (a possible 84.05% upside). 9 analyst firms have reported ratings in the last year.

Current Stock Price for Avid Bioservices (CDMO)?

The stock price for Avid Bioservices (NASDAQ: CDMO) is $6.52 last updated April 18, 2024 at 4:00 PM EDT.

Does Avid Bioservices (CDMO) pay a dividend?

There are no upcoming dividends for Avid Bioservices.

When is Avid Bioservices (NASDAQ:CDMO) reporting earnings?

Avid Bioservices’s Q4 earnings are confirmed for Thursday, June 20, 2024.

Is Avid Bioservices (CDMO) going to split?

There is no upcoming split for Avid Bioservices.

What sector and industry does Avid Bioservices (CDMO) operate in?

Avid Bioservices is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-